COVID-19 Leading to Accelerated Rapidly Progressive Interstitial Lung Disease in Anti-MDA5 Dermatomyositis

被引：0
作者：
Dandu, S. [1 ]
Farhat, F. [1 ]
Akhlaq, H. [1 ]
Udongwo, N. [1 ]
Nannepaga, S. [1 ]
Nadhim, A. [2 ]
Abu Homoud, A. [3 ]
机构：
[1] Jersey Shore Univ, Med Ctr, Internal Med, Neptune, NJ USA
[2] JSUMC, Neptune, NJ USA
[3] Jersey Shore Univ, Med Ctr, Pulm & Crit Care, Neptune, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2023年 / 207卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1445
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases
    Mehta, Asmita A.
    Paul, Tisa
    Cb, Mithun
    Haridas, Nithya
    BMJ CASE REPORTS, 2021, 14 (04)
  • [22] A Case of Anti-MDA5 Antibody Polymyositis with Rapidly Progressive Interstitial Lung Disease
    MacDonald, D.
    Syed, M. K. Hayat
    Ingbar, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [23] Assessment of anti-MDA5 antibody as a diagnostic biomarker in patients with dermatomyositis-associated interstitial lung disease or rapidly progressive interstitial lung disease
    Li, Liubing
    Wang, Qian
    Wen, Xiaoting
    Liu, Chenxi
    Wu, Chanyuan
    Yang, Funing
    Zeng, Xiaofeng
    Li, Yongzhe
    ONCOTARGET, 2017, 8 (44) : 76129 - 76140
  • [24] RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN ANTI-MDA5-ASSOCIATED DERMATOMYOSITIS
    Jackson, Ian P.
    Jackson, Collin
    Teplitsky, Ella
    Moore, Doug R.
    CHEST, 2023, 164 (04) : 3191A - 3192A
  • [25] Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease disguising as anti-synthetase syndrome
    Tanaka, Nao
    Terao, Chikashi
    Nakayama, Yoichi
    Sasai, Tsuneo
    Umezawa, Natsuka
    Yagyu, Yuriko
    Ito, Kanae
    Koike, Ryuji
    Nakashima, Ran
    Hatta, Kazuhiro
    Mizoguchi, Fumitaka
    RHEUMATOLOGY, 2021, 60 (03) : E104 - E106
  • [26] ANTI-MDA5 (+) CLINICALLY AMYOPATHIC DERMATOMYOSITIS-ASSOCIATED RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE: ROLE OF HEMOPERFUSION WITH POLYMYXIN
    Selva-O'callaghan, A.
    Vizcaino, C.
    Ruiz-Rodriguez, J. C.
    Trallero-Araguas, E.
    Ramos, N.
    Berastegui, C.
    Gil Vila, A.
    Martinez, M. A.
    Solanich, X.
    Ferrer, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1095 - 1095
  • [27] Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis
    Sakamoto, Noriho
    Ishimoto, Hiroshi
    Nakashima, Shota
    Yura, Hirokazu
    Miyamura, Takuto
    Okuno, Daisuke
    Hara, Atsuko
    Kitazaki, Takeshi
    Kakugawa, Tomoyuki
    Ishimatsu, Yuji
    Satoh, Minoru
    Mukae, Hiroshi
    INTERNAL MEDICINE, 2019, 58 (06) : 837 - 841
  • [28] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    So, Ho
    Wong, Victor Tak Lung
    Lao, Virginia Weng Nga
    Pang, Hin Ting
    Yip, Ronald Man Lung
    CLINICAL RHEUMATOLOGY, 2018, 37 (07) : 1983 - 1989
  • [29] Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis
    Ho So
    Victor Tak Lung Wong
    Virginia Weng Nga Lao
    Hin Ting Pang
    Ronald Man Lung Yip
    Clinical Rheumatology, 2018, 37 : 1983 - 1989
  • [30] Refractory cutaneous ulcers in anti-MDA5 dermatomyositis were not associated with rapidly progressive interstitial lung disease, and responded to tadalafil
    Ge, Yongpeng
    Jiang, Wei
    Lu, Xin
    Wang, Guochun
    Shu, Xiaoming
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 71
12345